Publications for Sanghoon Lee yuipapa@gmail.com

NYMC School of Medicine
  • Ganz, A., Galloza, S., Lee, S., & Baumstein, D. (2016). Complete resolution of resistant hypertension in a young female. American Journal of Kidney Diseases, 67(5), A46.

  • Lee, S., Yin, C., Shah, T., Ayello, J., Morris, E., van de Ven, C., & Cairo, M. (2016). Ruxolitinib, A JAK1/JAK2 inhibitor, significantly prolongs survival in both primary mediastinal B-cell lymphoma & hodgkin lymphoma xenograft NSG mouse model: A potential targeted adjuvant therapy. Pediatric Blood & Cancer, 63(Suppl 3), S10.

  • Lee, S., Yin, C., Shah, T., Ayello, J., Morris, E., Van De Ven, C., & Cairo, M. S. (2016). Upregulation of DLEU1 significantly prolongs survival in a rituximab-treated DLEU1 knockout human Burkitt lymphoma (BL) xenograft NSG mouse model: DLEU1 may act as a tumor suppressor gene in pediatric BL. Cancer Research, 76(14 (Suppl)), 3838. doi:10.1158/1538-7445.AM2016-3838

  • Lee, S., Yin, C., Ayello, J., Van De Ven, C., & Cairo, M. S. (2014). Clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (CAS) system mediated endogenous CD19 gene knockout model in burkitt lymphoma. Cancer Research, 74(19 Suppl.), 3617.

  • Lee, S. , Yin, C., O'Connell, T., Ayello, J., Van De Ven, C., & Cairo, M. S. (2014). Transcription activator-like effector nucleases (TALENs) mediated silencing of Bruton's tyrosine kinase (BTK) inhibits phosphorylation of Erk in Burkitt lymphoma . Cancer Research, 74(19 Suppl.), 3112.  doi:10.1158/1538-7445.AM2014-3112